XHKG
8372
Market cap12mUSD
Jun 27, Last price
0.12HKD
1D
-5.60%
1Q
6.31%
IPO
-64.24%
Name
Grand Brilliance Group Holdings Ltd
Chart & Performance
Profile
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks. It sells its products to various private and public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.
IPO date
Mar 29, 2018
Employees
41
Domiciled in
HK
Incorporated in
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
Income | |||||||||
Revenues | 81,903 6.78% | 76,701 6.56% | |||||||
Cost of revenue | 80,715 | 71,349 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,188 | 5,352 | |||||||
NOPBT Margin | 1.45% | 6.98% | |||||||
Operating Taxes | 420 | 1,815 | |||||||
Tax Rate | 35.35% | 33.91% | |||||||
NOPAT | 768 | 3,537 | |||||||
Net income | 7,855 3.87% | 7,562 86.81% | |||||||
Dividends | (3,200) | (2,400) | |||||||
Dividend yield | 4.23% | ||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 1,429 | 3,766 | |||||||
Long-term debt | 1,429 | 5,142 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (61,522) | (57,522) | |||||||
Cash flow | |||||||||
Cash from operating activities | 6,718 | 12,658 | |||||||
CAPEX | (1,804) | (63) | |||||||
Cash from investing activities | (395) | (510) | |||||||
Cash from financing activities | (7,420) | (6,399) | |||||||
FCF | (4,563) | 5,230 | |||||||
Balance | |||||||||
Cash | 60,466 | 61,858 | |||||||
Long term investments | 3,914 | 4,572 | |||||||
Excess cash | 60,285 | 62,595 | |||||||
Stockholders' equity | 48,285 | 44,672 | |||||||
Invested Capital | 56,420 | 58,033 | |||||||
ROIC | 1.34% | 6.07% | |||||||
ROCE | 1.13% | 5.21% | |||||||
EV | |||||||||
Common stock shares outstanding | 800,000 | 800,000 | |||||||
Price | 0.07 -5.33% | ||||||||
Market cap | 56,800 -5.33% | ||||||||
EV | (722) | ||||||||
EBITDA | 5,804 | 9,718 | |||||||
EV/EBITDA | |||||||||
Interest | 106 | 152 | |||||||
Interest/NOPBT | 8.92% | 2.84% |